KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Non-Current Debt (2016 - 2025)

Gilead Sciences (GILD) has disclosed Non-Current Debt for 16 consecutive years, with $22.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt fell 11.11% year-over-year to $22.1 billion, compared with a TTM value of $22.1 billion through Dec 2025, down 11.11%, and an annual FY2025 reading of $22.1 billion, down 11.11% over the prior year.
  • Non-Current Debt was $22.1 billion for Q4 2025 at Gilead Sciences, roughly flat from $22.1 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $27.9 billion in Q2 2021 and bottomed at $21.2 billion in Q2 2023.
  • Average Non-Current Debt over 5 years is $23.5 billion, with a median of $23.0 billion recorded in 2022.
  • The sharpest move saw Non-Current Debt soared 32.28% in 2021, then decreased 15.82% in 2023.
  • Year by year, Non-Current Debt stood at $25.2 billion in 2021, then dropped by 8.82% to $23.0 billion in 2022, then increased by 1.01% to $23.2 billion in 2023, then rose by 7.36% to $24.9 billion in 2024, then dropped by 11.11% to $22.1 billion in 2025.
  • Business Quant data shows Non-Current Debt for GILD at $22.1 billion in Q4 2025, $22.1 billion in Q3 2025, and $22.1 billion in Q2 2025.